chr6-166929652-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000508775.6(RNASET2):c.707G>A(p.Arg236Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000846 in 1,614,072 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R236W) has been classified as Benign.
Frequency
Consequence
ENST00000508775.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RNASET2 | NM_003730.6 | c.707G>A | p.Arg236Gln | missense_variant | 9/9 | ENST00000508775.6 | NP_003721.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RNASET2 | ENST00000508775.6 | c.707G>A | p.Arg236Gln | missense_variant | 9/9 | 1 | NM_003730.6 | ENSP00000426455 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000993 AC: 151AN: 152096Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.00156 AC: 393AN: 251356Hom.: 0 AF XY: 0.00169 AC XY: 230AN XY: 135878
GnomAD4 exome AF: 0.000831 AC: 1215AN: 1461858Hom.: 3 Cov.: 31 AF XY: 0.000866 AC XY: 630AN XY: 727222
GnomAD4 genome AF: 0.000992 AC: 151AN: 152214Hom.: 1 Cov.: 33 AF XY: 0.00117 AC XY: 87AN XY: 74418
ClinVar
Submissions by phenotype
Cystic leukoencephalopathy without megalencephaly Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 02, 2024 | - - |
RNASET2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 07, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at